[1]
Amine Bekadja, M., Michallet, M., Benzineb, B., Mesli, N., Ouldjeriouat, H., Serradj, F., Brahimi, M. and Yafour, N. 2021. Evaluation of Posaconazole for Primary Prophylaxis of IFI in Acute Myeloid Leukemia under Intensive Induction Chemotherapy. Comparative Real Life Study with Fluconazole in two Hematological Centers in Algeri. Asian Pacific Journal of Cancer Biology. 6, 4 (Dec. 2021), 249-254. DOI:https://doi.org/10.31557/apjcb.2021.6.4.249-254.